{"id":"ner1006","rwe":[{"pmid":"37593156","year":"2023","title":"Bowel cleansing effectiveness and safety of 1L PEG + Asc in the real-world setting: Observational, retrospective, multicenter study of over 13000 patients.","finding":"","journal":"Endoscopy international open","studyType":"Clinical Study"},{"pmid":"36514503","year":"2022","title":"Bowel cleansing efficacy of 1 L NER1006versus macrogol and 3 L polyethylene glycol using split-dose administration.","finding":"","journal":"JGH open : an open access journal of gastroenterology and hepatology","studyType":"Clinical Study"},{"pmid":"36064325","year":"2022","title":"Transient alterations in plasma sodium concentrations with NER1006 bowel preparation: an analysis of three phase III, randomized clinical trials.","finding":"","journal":"BMC gastroenterology","studyType":"Clinical Study"},{"pmid":"35078404","year":"2022","title":"1L NER1006 can improve rates of adequate and high-quality bowel cleansing in the right colon: a post hoc analysis of two randomised clinical trials.","finding":"","journal":"BMC gastroenterology","studyType":"Clinical Study"},{"pmid":"34653425","year":"2022","title":"Efficacy and safety of split-dose bowel preparation with 1 L polyethylene glycol and ascorbate compared with 2 L polyethylene glycol and ascorbate in a Korean population: a phase IV, multicenter, randomized, endoscopist-blinded study.","finding":"","journal":"Gastrointestinal endoscopy","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Norgine","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["IMP-1"],"company":"Norgine","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=NER1006","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:01:54.555736+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:02:01.110022+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NER1006","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:02:01.658897+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201479/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:02:02.361259+00:00"}},"allNames":["ner1006"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Ner1006's mechanism of action is currently unknown, but as a small molecule drug, it likely involves binding to a specific target, such as a protein or receptor, to produce its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=ner1006","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ner1006","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:25:44.176873","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:02:04.151823+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"ner1006","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07218523","phase":"PHASE3","title":"A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy","status":"RECRUITING","sponsor":"Norgine","startDate":"2025-12-29","conditions":["Bowel Cleansing Prior to Clinical Procedures"],"enrollment":212,"completionDate":"2027-01-06"},{"nctId":"NCT03437265","phase":"PHASE1","title":"A Pharmacokinetic Study of PLENVU® in Healthy Subjects","status":"COMPLETED","sponsor":"Norgine","startDate":"2020-09-03","conditions":["Pharmacokinetic"],"enrollment":19,"completionDate":"2020-10-05"},{"nctId":"NCT05174845","phase":"","title":"Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia","status":"COMPLETED","sponsor":"Norgine","startDate":"2021-10-01","conditions":["Colon Cancer","Colon Disease","Colon Cleansing"],"enrollment":13393,"completionDate":"2022-03-01"},{"nctId":"NCT04708366","phase":"PHASE4","title":"Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients","status":"UNKNOWN","sponsor":"University of Bologna","startDate":"2021-02-01","conditions":["Colon Disease"],"enrollment":846,"completionDate":"2022-05-15"},{"nctId":"NCT02254486","phase":"PHASE3","title":"Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults","status":"COMPLETED","sponsor":"Norgine","startDate":"2014-09","conditions":["Colon Cancer","Colorectal Carcinoma","Colon Cleansing"],"enrollment":621,"completionDate":"2015-06"},{"nctId":"NCT02273167","phase":"PHASE3","title":"Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.","status":"COMPLETED","sponsor":"Norgine","startDate":"2014-10","conditions":["Colorectal Cancer","Colorectal Carcinoma","Colon Cleansing"],"enrollment":849,"completionDate":"2015-08"},{"nctId":"NCT02273141","phase":"PHASE3","title":"Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.","status":"COMPLETED","sponsor":"Norgine","startDate":"2014-11","conditions":["Colorectal Cancer","Colorectal Carcinoma","Colon Cleansing"],"enrollment":515,"completionDate":"2015-08"},{"nctId":"NCT01714466","phase":"PHASE2","title":"Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy","status":"COMPLETED","sponsor":"Norgine","startDate":"2012-10","conditions":["Colon Cancer"],"enrollment":240,"completionDate":"2014-01"},{"nctId":"NCT01834742","phase":"PHASE1","title":"Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects","status":"COMPLETED","sponsor":"Norgine","startDate":"2011-04","conditions":["Colorectal Cancer"],"enrollment":161,"completionDate":"2011-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"chemblId":"CHEMBL1201479"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Norgine","relationship":"Original Developer"}],"publicationCount":22,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Norgine","recentPublications":[{"date":"2023 Aug","pmid":"37593156","title":"Bowel cleansing effectiveness and safety of 1L PEG + Asc in the real-world setting: Observational, retrospective, multicenter study of over 13000 patients.","journal":"Endoscopy international open"},{"date":"2022 Dec","pmid":"36514503","title":"Bowel cleansing efficacy of 1 L NER1006versus macrogol and 3 L polyethylene glycol using split-dose administration.","journal":"JGH open : an open access journal of gastroenterology and hepatology"},{"date":"2022 Sep 5","pmid":"36064325","title":"Transient alterations in plasma sodium concentrations with NER1006 bowel preparation: an analysis of three phase III, randomized clinical trials.","journal":"BMC gastroenterology"},{"date":"2022 Jan 25","pmid":"35078404","title":"1L NER1006 can improve rates of adequate and high-quality bowel cleansing in the right colon: a post hoc analysis of two randomised clinical trials.","journal":"BMC gastroenterology"},{"date":"2022 Mar","pmid":"34653425","title":"Efficacy and safety of split-dose bowel preparation with 1 L polyethylene glycol and ascorbate compared with 2 L polyethylene glycol and ascorbate in a Korean population: a phase IV, multicenter, randomized, endoscopist-blinded study.","journal":"Gastrointestinal endoscopy"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"NER1006","companyName":"Norgine","companyId":"norgine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:02:04.151823+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}